Continuing Medical Education to Improve Knowledge of Viral Hepatitis B-C in Primary Healthcare Workers

NCT ID: NCT05207163

Last Updated: 2022-09-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

88 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-02-10

Study Completion Date

2023-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of study is identifying the effectiveness of 'continuing medical education' (CME) to primary healthcare worker to improve knowledge about viral hepatitis B-C

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Viral Hepatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Received CME

Group Type EXPERIMENTAL

Continuing medical education

Intervention Type BEHAVIORAL

Education section about knowledge of transmissions, severity of viral hepatitis B-C and update treatment strategy of the HBV-HCV

Not received CME

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Continuing medical education

Education section about knowledge of transmissions, severity of viral hepatitis B-C and update treatment strategy of the HBV-HCV

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Currently working at Outpatient department, Primary-level hospitals
* Having Practicing Certificate
* Not attending any long-term education
* Accepting ICF

Exclusion Criteria

* Not attending the full number of lessons
* Not answering the questionnaire
Minimum Eligible Age

24 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pham Ngoc Thach University of Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Le Hong Duc

Lecturer - Researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lê H Đức, Medicine

Role: PRINCIPAL_INVESTIGATOR

Pham Ngoc Thach University of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lê Hồng Đức

Tháng 07, Ho Chi Minh City, Vietnam

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Vietnam

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

511/TĐHYKPNT-HĐĐĐ

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.